Attana AB (NGM:ATANA) Total Receivables: kr0.62 Mil (As of Mar. 2026)


What is Attana AB Total Receivables?

Attana AB NGM:ATANA -25.00% Total Receivables is kr0.62 Mil as of Mar. 2026. The stock has 4 warning signs investors should review.

Attana AB's Total Receivables for the quarter that ended in Mar. 2026 was kr0.62 Mil.

Attana AB Total Receivables Historical Data

* Premium members only.

The historical data trend for Attana AB's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Attana AB Total Receivables Chart

Attana AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Receivables
Get a 7-Day Free Trial Premium Member Only 1.86 4.16 7.77 0.89 0.91

Attana AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.09 3.15 0.42 0.91 0.62

Attana AB Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of kr0.62 Mil mean?
Attana AB (NGM:ATANA) has a Total Receivables of kr0.62 Mil as of Mar. 2026. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Attana AB and its competitors.
Is Attana AB's Total Receivables too high?
Attana AB's current Total Receivables is kr0.62 Mil.
How does Attana AB's Total Receivables compare to TMO and DHR?
Attana AB's Total Receivables of kr0.62 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Medical Diagnostics & Research company?
A good Total Receivables depends on the Medical Diagnostics & Research industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Attana AB and its competitors. Attana AB's current Total Receivables is kr0.62 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Attana AB stock overvalued right now?
Attana AB (NGM:ATANA) has a current Total Receivables of kr0.62 Mil. The current Total Receivables is kr0.62 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Attana AB (NGM:ATANA), the current Total Receivables is kr0.62 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Attana AB Business Description

Address Bjornnasvagen 21, Stockholm, SWE, SE-114 19
Attana AB offers biologically relevant information to improve efficiency and performance of pharmaceutical drug development.